Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Cardiol Young
; 31(3): 507-510, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-972116
ABSTRACT
The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Oxygen Inhalation Therapy
/
Ritonavir
/
Lopinavir
/
COVID-19 Drug Treatment
/
Hypoxia
/
Mucocutaneous Lymph Node Syndrome
Type of study:
Case report
/
Cohort study
/
Diagnostic study
/
Experimental Studies
/
Prognostic study
Topics:
Long Covid
Limits:
Child
/
Humans
/
Male
Language:
English
Journal:
Cardiol Young
Journal subject:
Vascular Diseases
/
Cardiology
/
Pediatrics
Year:
2021
Document Type:
Article
Affiliation country:
S1047951120004291
Similar
MEDLINE
...
LILACS
LIS